Lightnews — Scholar-powered news

Reposted by Jeffrey V Lazarus

CUNY Graduate School of Public Health & Health Policy @cunysph.bsky.social · 2d

🏈🩺 #CUNYSPH Prof. Bruce Y Lee explores NFL legend Dan Marino’s MASH (metabolic dysfunction–associated steatohepatitis) diagnosis in Forbes featuring insights from Prof. Jeffrey V Lazarus on the prevalence and public health risks of liver disease. cunysph.me/48CD1Vx

NFL Legend Dan Marino Talks About His MASH, Liver Disease Diagnosis

NFL Hall of Fame quarterback Dan Marino has revealed his metabolic dysfunction-associated steatohepatitis or MASH diagnosis. Here's what this liver disease is.

cunysph.me

1

Reposted by Jeffrey V Lazarus

CUNY Graduate School of Public Health & Health Policy @cunysph.bsky.social · 6d

A new Politico piece on chronic diseases quotes #CUNYSPH Prof. Jeffrey V Lazarus on how food environments shape health more than “individual choice”.

💬 “What are the options, what’s available, do you even have the ability to purchase healthy foods?”

Read more: cunysph.me/4gPQMT7

Chronic diseases are squeezing economies. Leaders don’t have much of a plan.

The United Nations General Assembly is expected to sign off on a watered-down commitment to tackle noncommunicable diseases.

cunysph.me

1 1

Jeffrey V Lazarus @jvlazarus.bsky.social · 6d

Tx for sharing. My question for Spain's secretary of health comes at 1 hour 9 min. It's about the commercial determinants of health and how Spain can reconcile its work to reduce NCDs while fomenting the sale of alcohol.
youtu.be/p3wYHX8I5eg?...
Our call to action:
www.thelancet.com/journals/lan...

Shaping the Spanish National Health System with a Global Health Perspective, Sept 18, 2025

YouTube video by CUNY SPH

youtu.be

Reposted by Jeffrey V Lazarus

Wilton Park @wiltonpark.bsky.social · 22d

💬 'Wilton Park has shown to be a powerful outlet to reach world leaders and shape strategic health discussions.'

In our latest blog, @jvlazarus.bsky.social explains how his partnership with Wilton Park has delivered policy impact.

#WiltonPark80

🔗 wiltonpark.org.uk/idea/80-year...

A view of Wiston House. Text reads: New blog - 80 years of Wilton Park: Professor Jeffrey V Lazarus

2 1

Reposted by Jeffrey V Lazarus

LIVERAIM @liveraim.bsky.social · Jul 28

🚨 Don't miss the third webinar of the #LIVERAIM series!

📹 youtube.com/watch?v=qdM_...

#SLDthinktank

@jvlazarus.bsky.social @ihieurope.bsky.social @easlnews.bsky.social @majathiele.bsky.social @salvatore-piano.bsky.social @aleksanderkrag.bsky.social

LIVERAIM webinar #3: A Deep Dive into Steatotic Liver Disease Policy and Regulatory Processes

YouTube video by LIVERAIM

youtube.com

2 2

Reposted by Jeffrey V Lazarus

LIVERAIM @liveraim.bsky.social · Jun 29

😶Liver disease is often suffered in silence.
Stigma and shame block care.

💡It’s a chronic illness, not consequence of bad choices.

🩺Everyone deserves support.
At #LIVERAIM, we’re breaking the silence.

#EndTheStigma #LiverHealthMatters #HealthEquity

@ihieurope.bsky.social @easlnews.bsky.social

2 4 4

Jeffrey V Lazarus @jvlazarus.bsky.social · Jun 29

Read about stigma in the EASL-Lancet liver health commission:
www.thelancet.com/journals/lan...
#LiverSky

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

Liver diseases have become a major health threat across Europe, and the face of European hepatology is changing due to the cure of viral hepatitis C and the control of chronic viral hepatitis B, the i...

www.thelancet.com

1

Reposted by Jeffrey V Lazarus

Nature Reviews Gastroenterology & Hepatology @natrevgastrohep.nature.com · Jun 9

Happy to support and endorse the People First Liver Charter in
‪‪@natmed.nature.com‬‬ www.nature.com/articles/s41...

We've always taken a sensitive approach to the language used in our journal, and will continue to do so. See this Editorial www.nature.com/articles/s41...

The People-First Liver Charter - Nature Medicine

Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...

www.nature.com

2 2

Reposted by Jeffrey V Lazarus

Philippa Matthews @pippa-matt.bsky.social · Jun 9

The People-First Liver Charter - opportunities for improving awareness, tackling stigma, building accessible care pathways, maintaining linkage to treatment/monitoring, & reducing health inequities.
🧪
Led by @jvlazarus.bsky.social
#NoHep #MedSky #HepSky #LiverSky
www.nature.com/articles/s41...

The People-First Liver Charter - Nature Medicine

Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...

www.nature.com

2 2

Jeffrey V Lazarus @jvlazarus.bsky.social · Jun 8

At the Global Think-tank on Steatotic Liver Disease, we launched the People-First Liver Charter
www.nature.com/articles/s41...

+ A call for doubling the diagnostic rate of at-risk MASH
www.thelancet.com/journals/lan...
#SLDthinktank #InMotionTogether #LiverSky

The People-First Liver Charter - Nature Medicine

Reducing the stigma and discrimination that people living with liver conditions experience requires rethinking how diagnoses, diseases, etiologies and circumstances are perceived — a shift that begins...

www.nature.com

1 6

Reposted by Jeffrey V Lazarus

ISGlobal @isglobal.org · May 29

Congratulations to @jvlazarus.bsky.social on receiving the Eugene T. Davidson Public Service Award from the American Association of Clinical Endocrinology!

This award recognises exceptional contributions to clinical excellence, research, public health, and community engagement in #endocrinology.

2 5

Jeffrey V Lazarus @jvlazarus.bsky.social · Apr 19

Here we are in Spanish talking liver health. #WorldLiverDay

ISGlobal @isglobal.org · Apr 19

Hoy, #DíaMundialDelHígado, hablamos de la enfermedad hepática crónica más frecuente del mundo y cómo prevenirla.

¡Ciencia #EnMenosDeUnMinuto para que ganes un quesito verde en el Trivial Pursuit!

Puedes ver más de esta serie en nuestro #TikTok: 🟠https://bit.ly/ISGlobal_TikTok

1 2

Jeffrey V Lazarus @jvlazarus.bsky.social · Apr 19

Food inequity and insecurity and MASLD: burden, challenges, and interventions
www.nature.com/articles/s41...
@natrevgastrohep.nature.com
is a major theme of #WorldLiverDay:
worldliverday.org/food-is-medi...
#LiverSky @easlnews.bsky.social #HealthyLiversHealthyLives

Food inequity and insecurity and MASLD: burden, challenges, and interventions - Nature Reviews Gastroenterology & Hepatology

Metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence is increasing worldwide, and a crucial risk factor is food insecurity. This Review provides an extensive overview of food in...

www.nature.com

1 3

Jeffrey V Lazarus @jvlazarus.bsky.social · Apr 19

We support the @ncdalliance priorities for the 4th United Nations High-level Meeting on NCDs Political Declaration sldthinktank.com/un-hlm-2025-... and further call on UN Member States to develop #BestBuy interventions to address SLD:
www.thelancet.com/journals/lan...

#LiverSky #SLDthinktank

https://sldthinktank.com/un-hlm-2025-nc…

1 4

Jeffrey V Lazarus @jvlazarus.bsky.social · Apr 19

Read about Chronic Liver Disease, MASLD/MASH, and the Global NCD Agenda in the context of the United Nations General Assembly High-level Meeting on NCDs this Sept. We need to take action every day and not just on #WorldLiverDay!
sldthinktank.com/un-hlm-2025-...
#liversky #SLDthinktank

2 2 3

Reposted by Jeffrey V Lazarus

LIVERAIM @liveraim.bsky.social · Apr 19

🌎Did you know 1 in 3 adults worldwide has #MASLD?
It’s tied to obesity, diabetes & high cholesterol, it can lead to fibrosis and cancer.
This #WorldLiverDay remember: #FoodIsMedicine!
💪Let's make #liverhealth a priority
@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social

1 7 6

Jeffrey V Lazarus @jvlazarus.bsky.social · Apr 5

"Food is Medicine" -But for whom? The accessibility problem in nutrition and liver health:
worldliverday.org/food-is-medi...
#WorldLiverDay #SLDthinktank #LiverSky
@easlnews.bsky.social @ebtapper.bsky.social @aleksanderkrag.bsky.social @debbieshawcross.bsky.social @melinamanolas.bsky.social

https://worldliverday.org/food-is-medici…

1 5

Reposted by Jeffrey V Lazarus

Hannes Hagström @liverepi.bsky.social · Mar 24

New paper from us in @jhepatology.bsky.social: www.journal-of-hepatology.eu/article/S016...
Causes of death in >13,000 persons with #MASLD - check it out #liversky. So proud of co-senior author Axel Wester and first author medical student Gabriel Issa for the work!

Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden

Data on cause-specific mortality in metabolic dysfunction-associated steatotic liver disease (MASLD) are limited. We aimed to determine the rate and risk of death from different causes in patients wit...

www.journal-of-hepatology.eu

1 6 17

Jeffrey V Lazarus @jvlazarus.bsky.social · Mar 26

It's a must-read #LiverSky

2

Reposted by Jeffrey V Lazarus

LIVERAIM @liveraim.bsky.social · Mar 20

❓Did you miss the second #LIVERAIM webinar?

Check out our Youtube channel and discover what an #earlydiagnosis of #chronicliverdisease truly means for patients!

🎥 www.youtube.com/watch?v=jmw5...

@easlnews.bsky.social @ihieurope.bsky.social @europeliver.bsky.social

Early diagnosis of Chronic Liver Disease - What does it means for patients?

YouTube video by LIVERAIM

www.youtube.com

1 5 4

Reposted by Jeffrey V Lazarus

Nature Reviews Disease Primers @natrevdiseaseprimers.nature.com · Mar 12

Metabolic dysfunction-associated steatotic liver disease encompasses a spectrum from metabolic dysfunction-associated steatotic liver or isolated hepatic steatosis through to metabolic dysfunction-associated steatohepatitis (#MASH). #MASLD
https://www.nature.c...

1 1

Jeffrey V Lazarus @jvlazarus.bsky.social · Mar 16

New Nature disease primer on #MASLD out now. MASLD affects 1 in 3 adults, yet it’s still underrecognized beyond #hepatology. That’s why our multidisciplinary team collaborated to cover epidemiology, diagnosis, treatment & prevention

🔗https://www.nature.com/articles/s41572-025-00599-1

#LiverSky

Rui Castro @ruicastrohd.bsky.social · Mar 12

In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published:

🔗 nature.com/articles/s41...

@jvlazarus.bsky.social

3

Reposted by Jeffrey V Lazarus

Rui Castro @ruicastrohd.bsky.social · Mar 12

In a related topic, more about MASLD in an amazing Nature Reviews Disease Primers article just published:

🔗 nature.com/articles/s41...

@jvlazarus.bsky.social

1 1

Jeffrey V Lazarus @jvlazarus.bsky.social · Mar 3

The second @liveraim.bsky.social webinar is now underway...! You can view the first webinar on demand here:
www.liveraim.eu/webinars/
#LiverSky LIVERAIM is working to improve early detection of chronic liver disease through the development of a new biomarker-based personalized risk calculator.

Reposted by Jeffrey V Lazarus

LIVERAIM @liveraim.bsky.social · Mar 2

📌Tomorrow is the day: don't miss the 2nd #LIVERAIM webinar!

✒️Register now! tinyurl.com/bdhyjv8e

@europeliver.bsky.social @easlnews.bsky.social @jvlazarus.bsky.social @aleksanderkrag.bsky.social @mkdmilan.bsky.social @majathiele.bsky.social @worldhepalliance.bsky.social

1 3 5